Register entry
Catalent U.K. Swindon Zydis Limited
- Registered sites
- 0
- Drug products
- 21
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
21Showing 21 of 21.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Asenapine Maleate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Asenapine Maleate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Asenapine Maleate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Asenapine Maleate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Asenaprine Maleate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Asenaprine Maleate | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Fingolimod Lauryl Sulfate | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Fingolimod Lauryl Sulfate | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | GLYCOPYRROLATE | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Loratadine | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Loratadine | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Odactra | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Olanzapine | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | RIMEGEPANT SULFATE | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Rizatriptan | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
| - | Short Ragweed Pollen Allergen Extract | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Timothy Grass Pollen Allergen Extract | TABLET | DRUG FOR FURTHER PROCESSING |
| - | selegiline hydrochloride | TABLET, ORALLY DISINTEGRATING | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.